Medsyn Biopharma
Northville, US · Delaware LLC
Find your way into Medsyn Biopharma
Sign up to see every warm intro you have to Medsyn Biopharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Medsyn Biopharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
JM
John Mel SorensenNamed on SEC filing
MS
Mel Sorensen JohnNamed on SEC filing
GS
Gilbert S. OmennNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$19.6M disclosed across 3 rounds · 2023–2025
▶$11.5MraisedNov 2025 · 16 investors · PharmaceuticalsRule 506(b)
▶$11.5MraisedNov 2025 · 16 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Martin MatthewExecutive Officer
- Brian WoodExecutive Officer
- John Mel SorensenExecutive Officer, Director
- Shaomeng WangDirector
- Offering amount
- $11.5M
- Amount sold
- $11.5M
- First sale
- Oct 2025
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$5MraisedAug 2024 · 5 investors · PharmaceuticalsRule 506(b)
▶$5MraisedAug 2024 · 5 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- John Mel SorensenExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $5M
- First sale
- Jul 2024
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$3.1MraisedMar 2023 · 6 investors · PharmaceuticalsRule 506(b)
▶$3.1MraisedMar 2023 · 6 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Mel Sorensen JohnExecutive Officer, Director
- Gilbert S. OmennDirector
- Offering amount
- $3.1M
- Amount sold
- $3.1M
- First sale
- Feb 2023
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Medsyn Biopharma raised?
- Medsyn Biopharma has disclosed $19.6M raised across 3 rounds.
- Where is Medsyn Biopharma headquartered?
- Medsyn Biopharma is headquartered in Northville, US.